Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children
Jason M. Glanz(Kaiser Permanente), Frank DeStefano(Abbott Fund), Matthew F. Daley(Kaiser Permanente), David L. McClure(Marshfield Clinic), Sophia R. Newcomer(University of Montana), Marlene M. Lugg(Kaiser Permanente), Michael L. Jackson(Kaiser Permanente Washington Health Research Institute), Roger Baxter(Unknown), Allison L. Naleway(Centers for Disease Control and Prevention)
Cited by 27
Related Papers
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
|The Pediatric Infectious Disease Journal|2004|381
Risk of Anaphylaxis After Vaccination of Children and Adolescents
|PEDIATRICS|2003|321